2008-12-02 06:41:22
All stock information and news updated each evening.
If you would like real time stock quotes, profit calculations and news, please sign in or become a member.
Listed Closing Values do not include regular dividends.

Symbol	Announced Date	Closing Value	Last Price	Closing Date	Profit	Annualized Profit
ABI	2008-06-12	$37.30	$27.81	2008-11-21	34.12 %	0.00 %

Additional Information

If the merger is completed, Applied Biosystems shareholders will receive $38.00 in cash or an amount of Invitrogen stock based on Invitrogen's 20-day volume-weighted average price. The purchase price will be paid 45 percent in cash and the rest in stock Each share for which a holder fails to make any election with respect to any Applied Biosystems stock, will be converted into the right to receive the combination of $17.10 in cash and 0.4543 of a share of Invitrogen common stock. An Applied Biosystems stockholder who makes a valid election to receive stock consideration will have the right to receive 0.8261 shares of Invitrogen common stock for each ABI share held. If the arithmetic average of the volume-weighted average price of Invitrogen common stock on each trading day during the 20 consecutive trading days immediately preceding the third business day prior to the effective time of the merger is less than $46.00 per share, the holder of each share of Applied Biosystems stock which is converted into a right to receive any portion of the merger consideration in the form of shares of Invitrogen common stock will, in addition, receive an amount in cash without interest equal to the product of the portion of a share of Invitrogen common stock which such holder has a right to receive multiplied by the lesser of $46.00 minus the 20-day volume-weighted average price of Invitrogen common stock and $2.31. However, if the 20-day volume-weighted average price of Invitrogen common stock is less than $43.69 per share, there will not be any cash paid in addition to the amount calculated as described above. There also will not be any adjustment in the merger consideration if the 20-day volume-weighted average price of Invitrogen common stock exceeds $46.00 per share. If the 20-day volume-weighted average price of Invitrogen common stock is less than $46.00 per share, then holders of Applied Biosystems stock who receive all or a portion of their consideration in shares of Invitrogen stock will also receive an additional cash amount of up to $1.05 per share of Applied Biosystems stock if such holder elects mixed consideration, or up to $1.91 per share of Applied Biosystems stock if such holder elects stock consideration. Applied Biosystems stockholders who receive cash only will not receive any additional amounts.

Applied Biosystems Merger News:

Date	Update
2008-06-12	Invitrogen Buys Applied Biosystems for $6.7 Billion
2008-07-29	Merger of Invitrogen and Applied Biosystems Receives U.S. Antitrust Approval
2008-08-21	Applied Biosystems Inc. Declares Dividend (Business Wire)
2008-08-25	Applied Biosystems Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger With Invitrogen Corporation (Business Wire)
2008-09-11	Invitrogen and Applied Biosystems Announce Filing and Effectiveness of Definitive Joint Proxy Statement/Prospectus (Business Wire)
2008-09-16	Invitrogen sees Applied Biosystems deal by November (at Reuters)
2008-09-17	Invitrogen nears funding completion for buyout (AP)
2008-10-06	Leading Proxy Advisory Firms Recommend That Invitrogen and Applied Biosystems Shareholders Approve Merger (Business Wire)
2008-10-07	Invitrogen says outside advisers endorse buyout (AP)
2008-10-07	Invitrogen Files Merger Notification With European Commission (Business Wire)
2008-10-09	UPDATE - Invitrogen raises EPS view, says merger on track (at Reuters)
2008-10-15	Invitrogen and Applied Biosystems Amend Merger Agreement to Eliminate Tax Opinion Condition; Stockholder Meetings to Be Moved to October 28, 2008 (Business Wire)
2008-10-28	Invitrogen Shareholders Approve Merger with Applied Biosystems (Business Wire)
2008-10-28	Applied Biosystems Stockholders Approve Merger with Invitrogen (Business Wire)
2008-11-11	Invitrogen and Applied Biosystems Announce European Commission Merger Clearance (Business Wire)
2008-11-20	Invitrogen and Applied Biosystems Announce Preliminary Results of Election Regarding Merger Consideration (Business Wire)
2008-11-21	Invitrogen and Applied Biosystems Complete Merger (Business Wire)

View Closing Conditions for the Applied Biosystems (ABI) Merger

View Financing Conditions for the Applied Biosystems (ABI) Merger

MergerInvesting.com is an information service and is not a recommendation, an offer, or a solicitation of an offer to buy or sell securities. The information and data on this website are provided on an "AS IS, AS AVAILABLE" basis without warranty of any kind. MergerInvesting.com makes no guarantee as to the accuracy or completeness of this information. All information is provided for informational purposes only, and MergerInvesting.com shall not be liable for any errors or omissions, or for any action taken because of this information. At any time MergerInvesting.com's affiliates may maintain long or short positions in the securities listed in this report.

Copyright 2008 MergerInvesting.com

Privacy Policy